MANKINDPharmaceuticals
Mankind Pharma Ltd — Quarterly Results & Earnings
₹2005.80
+0.73%
Profit Growth YoY-22.00%Latest quarter
Sales Growth YoY20.77%Latest quarter
Sales CAGR 5Y15.79%5 year compound
Profit CAGR 5Y11.73%5 year compound
📋
Quarterly Performance
YoY Profit Growth-22.00%
🔴 Significant decline
YoY Sales Growth+20.77%
🔥 Exceptional growth
OPM 5Y Average
24.52%Operating profit margin
EPS Growth 5Y
11.08%Interest Coverage
3.88Higher = safer debt servicing
ROE
14.68%ROCE
15.98%💡
Growth Analysis
Mankind Pharma Ltd reported YoY profit growth of -22.00% and revenue growth of 20.77% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 15.79% and profits at 11.73% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Mankind Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.